BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15634660)

  • 1. Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death.
    Bergeron S; Beauchemin M; Bertrand R
    Mol Cancer Ther; 2004 Dec; 3(12):1659-69. PubMed ID: 15634660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
    Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K
    Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
    Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
    Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
    Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
    J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
    Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
    Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS
    Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts.
    Kuang AA; Diehl GE; Zhang J; Winoto A
    J Biol Chem; 2000 Aug; 275(33):25065-8. PubMed ID: 10862756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.
    Wen J; Ramadevi N; Nguyen D; Perkins C; Worthington E; Bhalla K
    Blood; 2000 Dec; 96(12):3900-6. PubMed ID: 11090076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
    Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for the cytotoxic ligand TRAIL.
    Pan G; O'Rourke K; Chinnaiyan AM; Gentz R; Ebner R; Ni J; Dixit VM
    Science; 1997 Apr; 276(5309):111-3. PubMed ID: 9082980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain.
    Meng XW; Heldebrant MP; Kaufmann SH
    J Biol Chem; 2002 Feb; 277(5):3776-83. PubMed ID: 11729181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.